- Home
- Equipment
- usa massachusetts
- precision engineered medicines
Refine by
Precision Engineered Medicines Equipment Supplied In Usa Massachusetts
9 equipment items found
by:Neoclease based inBoston, MASSACHUSETTS (USA)
Neoclease is pioneering the future of precision medicine through advanced technology in synthetic biology and generative AI. By developing synthetic nucleases, the company enhances gene editing processes to achieve unprecedented specificity and efficacy. These enzymes are meticulously crafted using proprietary algorithms powered by state-of-the-art GPT neural networks, which are capable of ...
Manufactured by:Ariana Pharma based inParis, FRANCE
Ariana Pharma has developed KEM® (Knowledge Extraction and Management) the most advanced Explainable Artificial Intelligence platform based on Galois Lattices (also known as Formal Concept Analysis or FCA). KEM® uses association rules to fully explore complex datasets in order to reveal hidden relationships and to derive new hypotheses. Ariana’s eXplainable Al reduces billions of ...
by:Iterative Health, Inc. based inCambridge, MASSACHUSETTS (USA)
AI-assisted clinical trial recruitment: the way forward. Our AI Recruitment technology specifically addresses patient recruitment pain points in the clinic. It’s also great for accelerating the approval timeline on novel IBD ...
by:Psychē Systems Corporation based inHopkinton, MASSACHUSETTS (USA)
No two people’s bodies are exactly the same, so it stands to reason that people will react to medicines and treatments in different ways. While medical treatments can have broad, overall positive results, those results become varied when you examine the results in individual people and even in specific populations. That’s where precision medicine comes in. Precision medicine is the ...
Manufactured by:Ariana Pharma based inParis, FRANCE
Ariana® has consolidated multiple, publicly available administrative healthcare admissions databases into a locally searchable observational health data resource of patient hospitalization, outpatient and other episodes, comprising in excess of 6B records. ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
Manufactured by:Kura Oncology, Inc. based inSan Diego, CALIFORNIA (USA)
With the advent of precision medicines that can target unique molecular or genetic features of a patient’s tumor, the field of oncology has a host of alternatives to one-size-fits-all treatments. This is a major advance over traditional chemotherapy, which can be as potent against healthy tissue as it is against cancer. Using tumor genomic profiling and biomarker strategies, physicians can ...
Manufactured by:Ardigen based inKraków, POLAND
Bioinformatics Analysis & Drug Discovery in the era of Artificial Intelligence. The digital CRO team brings together scientists and engineers with diverse skill sets, ranging from biology and chemistry to statistics and machine learning. We work with both small startups and big pharmas to leverage digital power in order to enable the development of new therapies. We ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The healthcare market is driven by the need to enhance efficiency and efficacy. Delivering on both, minimally invasive image-guided therapies are changing the way healthcare can be provided. And the market is growing: The global population aged 60 and older is projected to reach nearly 2.1 billion by 2050, versus 962 million in 2017.1 This means that the number of patients in all fields will be ...